NCT00679718View on ClinicalTrials.gov

A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions
Dry Eye Disease
Interventions
DRUG

diquafosol tetrasodium (INS365) ophthalmic solution

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00679718 - A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease | Biotech Hunter | Biotech Hunter